A-192621 CAS No.195529-54-5
A-192621 CAS No.195529-54-5
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-R-1962 | 5mg | 280.00 | + Add to cart  | 
																					|
| R-R-1962 | 10mg | 460.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							A-192621/CAS No.195529-54-5 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621 promotes apoptosis in PASMCs. A-192621 alos causes elevation of arterial blood pressure and an elevation in the plasma ET-1 level.
								| Appearance | N/A | 
|---|---|
| Molecular Weight | 558.66 | 
| Purity | >90% | 
| CAS | 195529-54-5 | 
| Formula | C33H38N2O6 | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 2 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds of A-192621 CAS No.195529-54-5 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

